¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ \avgXndI  
x)2ZbIDB:"  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© KZsJ_t++!W  
}C{wGK+o[  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© RATW[(ZA  
}woNI  
1.Co-stimulators (or co-stimulating molecules) .^FdO$"  
IaYy5Rw  
2.NK-kB "D/\&1.&  
qa)Qf,`  
3.Immunoglobulin superfamily %1PNP<3r0  
H.s:a#l?  
4.antigen-presenting cell (APC) ,mvU`>Ry  
Jbqm?Fy4X  
5.death domain wD`jks  
@6z]Xb  
6.CCR and CXCR De:| T8&  
[<A|\d'x  
7.Lectin (or mitogen) }SBpc{ch  
}*M>gvPo  
8.Clusters of differentiation, CD) 1usLCG>w{  
tG(!d$^  
9.B7 family )_Wo6l)i  
u(g0Ob  
10.Cytotoxic T lymphocyte, CTL) rIZ^ix-N  
-jQM h  
11.IL-15 and IL-15 receptor (IL-15R) pv;ZR  
>]S-a-|Bp  
12.MHC restriction NE2P "mY  
tc<ly{ 1c  
13.Affinity-chromatography 1|/]bffg!c  
qA5PIEvdq  
14.Cyctosprin A, CsA %[H|3  
{ x/~gp  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) JUlCj #%  
QFX )Nov];  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© = & =#G3f  
&d/x1=  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 2qxed e  
9L9+zs3 k  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ b?{\t;  
?kKr/f4N  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ Q/<?v!h{  
p`2w\P3;)  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© =9y&j-F  
B #zU'G*Y  
ÃâÒßѧרҵ£º l0-zu6i w  
t2 0Es  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ %AnqT|\#,  
"[t b-$ER  
Ïû»¯ÄÚ¿Æ£º (n0h#%  
-K*&I!  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ N497"H</  
X[r\ Qa  
ѪҺ²¡Ñ§×¨Òµ£º }Z Nyd  
+(l(|lQy$  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»